Gastroenterological Society of Australia (GESA), Melbourne, 2021. 5p.
The latest information about the concerns, safety, efficacy, choices etc. for people with liver disease.
Nature Reviews Gastroenterology and Hepatology, London, 2021. 17p.
Discusses the hepatotropism of SARS-CoV-2, the liver histology features present in patients with COVID-19, and an overview of the pattern and relevance of abnormal liver biochemistry during COVID-19.
Infectious Disease Advisor, New York, 2021. 5p. conference review
Summaries of a selection of COVID 19 cases (shared at American Academy of PAs conference) including patients with acute hepatitis, peripheral ischemia, or bilateral pulmonary embolism.
National Drug & Alcohol Research Centre (NDARC), Sydney, 2021. 9p.
Highlights the percentage of participants amongst a sample of people who regularly inject drugs in Sydney, NSW who reported having trouble accessing sterile needles in the past month, from 2011-2019.
Hepatitis Australia, Canberra, 2021. 2p factsheet
Also called Hepatitis D. General information about how is it transmitted, who is at risk, symptoms and treatment.
Int Network on Hepatitis in Substance Users (INHSU), Zurich, 2021. 4p.
Feedback from a series of point-of-care-testing (POCT) events led by people who use drugs, for people who use drugs. One of the main takeaways was that people who use drugs preferred other people with lived experience to do POCT.
ABC News, Western Sydney, 2021. 5p. news article
The program is staffed by peers and medical staff and aims to reach pockets of the community that are being missed by other programs.
Drug & Alcohol Review (via Wiley Online), 2021. 1p. detailed abstract
Evaluation of self-reported and serologically confirmed HCV status concordance among a sample of Australian people who inject drugs.
Medical News Today, Bexhill-on-Sea, 2021. 7p.
Looks at exposure to HCV before or during birth, whether the virus can affect pregnancys, and how doctors diagnose and treat the infection in children.
The Lancet Public Health, London, 2021. 15p open access.
Findings support the development of interventions that simultaneously address homelessness and unstable housing and HIV and HCV transmission in this population.
HCP Live, USA, 2021. 5p. article review
DAA treatment scale-up associated with a reduced incidence of chronic hep C virus in prison - indicative of the effect of treatment-as-prevention.
LiverWELL (Hepatitis Vic), Melbourne, 2021. App.
Create reminders for medication, appointments, track tests, keep notes, link to liver health news and guides on healthy living. Multiple languages.
HCV Action, London, 2021. Webinar 1 hr
Presentations incl: importance of outreach, van-based outreach, good practice sharing, and ‘Point of Care Test and Treat Roadshow’.
Penington Institute, Melbourne, 2021. Magazine
For frontline workers in Aust’s Needle and Syringe programs to help provide the critical knowledge and keep clients healthy.
Infohep, London, 2021. 2p article review
From Swiss HCVree trial: MSM living with HIV and hep C received DAAs. Men who reported sexual risk behaviour also received risk reduction counselling. (Link provided to original article).
Centers for Disease Control & Prevention, Atlanta GA, 2020.
Overview of info with a focus on how the virus is transmitted.
Kirby Institute, Sydney, 2021. Website.
A comprehensive guide to scale-up of testing and antiviral treatment for hepatitis C in the prison system. Contains resources for correctional authorities and health care providers.
Medical News Today, Bexhill-on-Sea, 2021. 7p
Looks at hepatitis C in children: the signs and symptoms of HCV infection and how doctors diagnose, monitor, and treat the condition.
Hepatitis NSW, Sydney, 2021. Webpages
Provides information covering testing, transmission, prevention and vaccination, treatment, and monitoring – as well as personal stories and specialist articles – to Chinese and Korean people residing in New South Wales.
Aust Govt Dept of Health, Canberra, 2021. 16p.
Aims to support nationally relevant research, innovation, and capacity building.
Public Health England, London, 2021. 6p.
Provides an overview of the impact of elimination activities on service users and health inequalities.
World Health Organization, Geneva, 2021. 106p.
The report describes WHO’s important contributions at regional and global level and identifies common actions across the 3 disease areas as well as gaps and priorities as a baseline for the next strategies.
Rights Reporter Foundation, Hungary, 2020. 37 minute video.
4 veterans of the user movement in Australia (from AIVL, NUAA and CAHMA) tell us the oral history of the movement especially around harm minimization and stigma.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.